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Abstract 
The GluN2A subunit of NMDA receptors (NMDARs) plays a critical role during postnatal brain 
development as its expression increases while Glun2B expression decreases.  Mutations and 
polymorphisms in GRIN2A gene, coding for GluN2A, are linked to developmental brain 
disorders such as mental retardation, epilepsy, schizophrenia. Published data suggest that 
GluN2A is involved in maturation and phenotypic maintenance of parvalbumin interneurons 
(PVIs), and these interneurons suffer from a deficient glutamatergic neurotransmission via 
GluN2A-containing NMDARs in schizophrenia.  
In the present study, we find that although PVIs and their associated perineuronal nets (PNNs) 
appear normal in anterior cingulate cortex of late adolescent / young adult GRIN2A KO mice, a 
lack of GluN2A delays PNN maturation. GRIN2A KO mice display a susceptibility to redox 
dysregulation as sub-threshold oxidative stress and subtle alterations in antioxidant systems are 
observed in their prefrontal cortex. Consequently, an oxidative insult applied during early 
postnatal development increases oxidative stress, decreases the number of parvalbumin-
immunoreactive cells, and weakens the PNNs in KO but not WT mice. These effects are long-
lasting, but preventable by the antioxidant, N-acetylcysteine. The persisting oxidative stress, 
deficit in PVIs and PNNs, and reduced local high-frequency neuronal synchrony in anterior 
cingulate of late adolescent / young adult KO mice, which have been challenged by an early-life 
oxidative insult, is accompanied with microglia activation. 
Altogether, these indicate that a lack of GluN2A-containing NMDARs alters the fine control of 
redox status, leading to a delayed maturation of PNNs, and conferring vulnerability for long-term 
oxidative stress, microglial activation, and PVI network dysfunction. 
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1. Introduction 
Parvalbumin-expressing interneurons (PVIs) are fast-spiking GABAergic neurons that form 
inhibitory synapses onto either cell body or axon initial segment of pyramidal neurons. Via feed-
forward and feed-back inhibitions, these interneurons exert a precise temporal control on the 
information flowing through their target neurons. Interconnected PVIs constitute a neuronal 
network able to synchronize the excitatory state of large numbers of neurons (Bartos et al., 
2007). Thus, PVIs coordinate the activity of neuronal assemblies in high-frequency synchrony 
(Cardin et al., 2009; Fuchs et al., 2007; Massi et al., 2012; Sohal et al., 2009), thereby 
modulating the processing of information required for sensory perception, working memory, 
attention, learning and memory, and social behavior (Billingslea et al., 2014; Hu et al., 2014). 
Anomalies in PVIs and their associated networks are key pathological features of 
schizophrenia (SZ) (Beasley and Reynolds, 1997; Lewis et al., 2012). Moreover, the specialized 
extracellular matrix (perineuronal nets, PNNs), which envelops many PVIs, is also abnormal in 
this disease (Enwright et al., 2016; Mauney et al., 2013; Pantazopoulos et al., 2015). The 
immature developmental gene expression profile of PVIs in SZ (Gandal et al., 2012) suggests a 
defect in the proper phenotypic maturation of these interneurons, which are particularly sensitive 
to perturbations during brain development (Steullet et al., 2016). Some of the proposed 
mechanisms underlying PVI anomalies in SZ are aberrant wiring of PVIs within neuronal 
networks, impaired glutamatergic inputs onto these interneurons and deleterious effects of 
neuroinflammation and oxidative stress (Lewis et al., 2012; Steullet et al., 2016). Impaired 
NMDA receptor (NMDAR)-dependent signaling, which represents a major pathological pathway 
in SZ (Coyle et al., 2012; Poels et al., 2014; Steiner et al., 2013), affects PVIs (Behrens et al., 
2007) and neuronal network activity (Carlen et al., 2012; Homayoun and Moghaddam, 2007; 
Kocsis et al., 2013; Korotkova et al., 2010). These interneurons are particularly sensitive to 
NMDAR antagonists during their development and maturation (Abekawa et al., 2007; Powell et 
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al., 2012; Wang et al., 2008). However, the contribution of the different subtypes of NMDARs to 
the effect of general NMDAR antagonists is not well established. 
NMDARs, which are ionotropic glutamate receptors, are heterotetramers consisting of two 
obligatory GluN1 subunits and two variable subunits (GluN2A, GluN2B, GluN2C, GluN2D, 
GluN3A, or GluN3B). The subunit composition of NMDARs determines the kinetic of calcium 
entrance upon receptor activation and the nature of the activated intracellular signaling (Paoletti 
et al., 2013). Therefore, distinct subtypes of NMDARs convey different functions. The GluN2A 
subunit, whose expression increases during early postnatal life, is involved in cortical network 
refinement during development via its actions on structural and functional synaptic plasticity 
(Cho et al., 2009; Fagiolini et al., 2003). Cortical PVIs undergo an early postnatal and activity-
dependent switch of the GluN2 subunit composition of NMDARs, with GluN2A becoming more 
numerous than GluN2B subunits (Matta et al., 2013; Zhang and Sun, 2011). The postnatal 
increase of GluN2A in PVIs coincides with the maturation of these interneurons and the PNN 
formation. Studies using antagonists targeting preferentially either GluN2A - or GluN2B-
containing NMDARs suggest that GluN2A, not GluN2B, contribute to PVI maturation and 
phenotypic maintenance (Kinney et al., 2006; Zhang and Sun, 2011). A disrupted function of 
GluN2A-containing NMDARs, as suggested by genetic studies, might therefore result in 
aberrant maturation and function of PVIs in some patients. Indeed, a few mutations in GRIN2A, 
the gene encoding GluN2A, have been identified in SZ (Hardingham and Do, 2016; Tarabeux et 
al., 2011). The locus containing GRIN2A is also associated with schizophrenia in a large 
genome wide association study (Consortium, 2014). The high-risk polymorphisms of GT repeats 
on the GRIN2A promoter give rise to reduced transcription (Liu et al., 2015), and reduced 
GluN2A expression, have been reported in prefrontal cortex (Beneyto and Meador-Woodruff, 
2008) and PVIs (Bitanihirwe et al., 2009). 
Although pharmacological manipulations support a role of GluN2A in development and 
phenotyping maintenance of PVIs, a demonstration of such function via genetic deletion of 
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GRIN2A was missing. Moreover, how the GluN2A-mediated signaling disruption impact PVIs 
remain unclear. Redox dysregulation / oxidative stress, which is widely reported in 
schizophrenia (Do et al., 2009; Flatow et al., 2013; Kim et al., 2016; Yao and Keshavan, 2011), 
is a common endpoint of many genetic and environmental risk factors leading to defects in PVIs 
and their associated PNNs in the prefrontal cortex, namely the anterior cingulate cortex (ACC) 
(Steullet et al., 2017). In a recent perspective article, we briefly disclosed that PVI and PNN 
deficits are also accompanied with oxidative stress in GRIN2A KO mice. Here, we further 
explored the relationship between PVIs, PNNs and oxidative stress in the ACC of mice lacking 
GluN2A-containing NMDARs during postnatal development. 
   
2. Methods 
2.1.  Animals. 
GRIN2A KO mice (Sakimura et al., 1995) were provided by A. Lüthi (University of 
Lausanne). They were backcrossed with C57BL/6J mice through many generations and housed 
under a 12-hour light-dark cycle in groups of 3–5 individuals/cage. Experiments were performed 
on both sexes and approved by the Local Veterinary Office. 
2.2. GBR12909 and N-acetylcysteine treatments 
GBR12909 (GBR, 10 mg/kg i.p.) (BioTrend, Switzerland) was injected daily from 
postnatal days 10 to 20. The vehicle solution, a phosphate buffer saline solution (PBS), was 
used in control animals. N-acetylcysteine (NAC) (PharmaNAC, BioAdvantexPharma, Canada) 
was provided in drinking  water (2.4 g/L) to the lactating mothers from postnatal days 7 to 20 
(das Neves Duarte et al., 2012). 
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2.3. Perfusion and tissue preparation 
For immunohistochemistry, mice were anesthetized and perfused with 4% 
paraformaldehyde. Coronal frozen sections (50-µm thick) of fixed brains were prepared and 
stored in ethylene glycol at -20 °C until use. For mRNA quantification, Western blots and GSH 
measurements, brains were quickly dissected out and sliced (2-mm thick) using a brain matrix. 
Slices were immediately stored at -80°C until use. Tissue from the medial prefrontal cortex was 
extracted from frozen brain slices using a tissue punch.   
2.4. Immunohistochemistry 
Triple immunolabeling for oxidative stress, parvalbumin (PV), and perineuronal nets (PNNs) was 
performed as followed. An antibody against 8-oxo-2'-deoxyguanosine (8-oxo-dG), a product of 
DNA oxidation, was used as oxidative marker, while the PNNs were labeled with the lectin 
Wisteria Floribunda Agglutinin (WFA), which binds the N-acetylgalactosamines in chondroitin 
sulfate proteoglycans (Berretta et al., 2015; Wang and Fawcett, 2012). Brain sections containing 
the anterior cingulate cortex (ACC) were first incubated with PBS + Triton 0.3% + sodium azide 
(1g/L) containing 2-3% normal horse serum, then placed for 48 hours in a solution with a mouse 
monoclonal anti-8-oxo-dG (1:400; AMS Biotechnology,  Switzerland) and a rabbit polyclonal 
anti-parvalbumin (PV) (1:2500; Swant Inc, Switzerland) primary antibody together with the 
biotin-conjugated WFA  (1:2000; Sigma, Switzerland). Sections were then washed, incubated 
with fluorescent secondary antibody conjugates: goat anti-mouse Alexa 488 (1:300; Life 
Technologies, USA), goat anti-rabbit CY3 (1:300; Chemicon International, USA) and 
streptavidin 405 conjugate (1:300; Millipore Corporation, USA). For dual immunolabeling of Iba1 
and CD68 to label microglia, normal donkey serum (2%) was used as blocking agent. Primary 
antibodies were a goat polyclonal anti-Iba1 (1:1000; Abcam, UK) and a rat monoclonal anti-
CD68 (1:1500; Abcam) antibody. Secondary antibody conjugates were a chicken anti-
goat Alexa 594 (1:300; Life Technologies, USA) and a chicken anti-rat Alexa 488 (1:300; Life 
Technologies, USA). 
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Sections were visualized and processed with a Zeiss confocal microscope equipped with x10, 
x40 and x63 Plan-NEOFLUAR objectives. All peripherals were controlled with LSM 710 Quasar 
software (Carl Zeiss AG, Switzerland). With the triple immunolabeling of 8-oxo-dG, PV, and 
WFA, Z-stacks of 12 images (with a 2.13 µm interval) were scanned (1024 x 1024 pixels).  
Images were filtered with a Gaussian filter to remove background noise and sharpen cell profile 
contour. Only the inner 8 images of Z-stacks were used for the analyses. The stack images 
were merged in a tif file with Imaris, and further analyzed with Image J.  Analyses were 
performed in a delineated region of interest (ROI) comprising the ACC (cg1) by an observer 
unaware of the experimental groups. For PV-IR, the number of PV-IR cell bodies was counted 
and the mean intensity of labeling (arbitrary unit) was measured separately within PV-IR cell 
bodies and  PV-IR processes. PV-IR processes included all PV-labeled voxels that were not 
part of the identifed PV-IR cell bodies. The mean intensity (arbitrary unit) was used as a 
measure for 8-oxo-dG-IR and WFA labeling. Because the image acquisition, the defined ROI, 
and the image analysis were slightly different to those used in Steullet et al. (2017), the intensity 
of 8-oxo-dG (arbitrary unit) and the numbers of PV-IR cells / ROI in the present study were not 
identical to those reported in the above article. However irrespective of the analytical method 
used, the differences between experimental groups were similar. The number of PV-IR neurons 
surrounded by WFA-labeled PNNs was also counted in IMARIS software (Bitplane AG, 
Switzerland) as described previously (Cabungcal et al., 2013a). Data are based on 4 non-
contiguous sections per mouse. For dual Iba1 and CD68 immunolabeling, Z-stacks of 20 
images (with a 1.2 µm interval) were scanned. The numbers of immunoreactive cells in the ACC 
ROI, using only the inner 18 images of Z-stacks, were counted using the spot tool of IMARIS. 
Data are based on two non-contiguous sections per mouse. 
2.5. mRNA quantification 
RNAs were extracted from the medial prefrontal cortex using RNeasy Mini Kit (Qiagen, 
Germany) as described in the manufacturer’s protocol.  cDNA were synthesized using  300 ng 
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RNA in a reaction mixture containing RT-buffer 10x,  5.5 mM MgCl2, 2 mM dNTP, 0.4 U/μl 
RNase Inhibitor, 2.5 μM Random Hexamers, and 1.25 U/μl RTase (Thermo Fisher Scientific, 
Waltham, USA). Taqman real time PCR was performed in a final volume of 20 μl containing 10 
ng cDNA, 1 μl of selected probes mixed with 10 μl of TaqMan Universal PCR Master Mix 
(Thermo Fisher Scientific). Probes used were: GPX1 (Mm00656767_g1), GCLM 
(Mm00514996_m1), GCLC (Mm00802655_m1), TXNIP (Mm01265659_g1), SRXN1 
(Mm00769566_m1), PPARGC1A (Mm01208835_m1), RPL27 (Rn00821099_g1), and β-Tubulin 
(TBB5) (Mm00495806_g1). Quantitative PCR was performed on Thermofisher 7500 Real-Time 
PCR System and the 7500 System SDS Software as established by the provider. Samples were 
run in duplicate. Values were normalized to the internal controls TBB5 and RPL27, and to a 
mixture of prefrontal samples. Data were analyzed using the ΔΔCt method. 
2.6. Western Blots 
Tissue from the medial prefrontal cortex were lysed in RIPA buffer (50 mM Tris-HCl, 150 
mM NaCl, 1% SDS, 1mM dithiothreitol, 1 mM EDTA, 0.1% Triton, 0.6 mM 
phenylmethanesulfonyl fluoride, 30 mM NaF, 30 mM β-glycerophosphate, 0.2 mM 
orthovanadate and protease inhibitor cocktail (Roche)), sonicated and centrifuged for 15 min at 
10000 g.  Tissue lysates were boiled at 95°C for 10 min in loading buffer (0.5 M Tris pH 6.8, 
Glycerol 30%, SDS 10%, beta-mercaptoethanol 5%, bromophenol blue 0.012%). Proteins were 
separated by SDS-PAGE on 12.5% nitrocellulose membranes, and transferred on PVDF 
membranes. After blocking in Tris-buffered saline (TBS) containing 2.5% milk, membranes were 
incubated overnight at 4°C with primary antibodies diluted in TBS with 01% Tween 20 and 3% 
BSA, followed by 1-h incubation with fluorescent secondary antibodies and a subsequent wash 
with TBS. Signals were visualized and analyzed with an Odyssey Clx imaging system (LI-COR 
Biosciences, Lincoln, USA) using β-actin for normalization. 2-cys peroxiredoxins (Prxs) were 
labeled irrespective of their redox state using a mouse anti-2-Cys Prxs (1:1000, Abcam), while 
the hyperoxidized Prxs (Prx-SO2/3H) were visualized with a rabbit anti-Prx-SO2/3H (1:2000, 
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Abcam). Normalization was performed using a mouse anti-β-actin (1:20000, Abcam). 
Secondary antibodies were IRDye 800CW Goat anti-Mouse IgG (H + L) (1:10000, LI-COR 
Biosciences), IRDye® 680RD Goat anti-Rabbit IgG (H + L) (1:10000, LI-COR Biosciences). 
2.7. GSH and oxidized GSH (GSSG) quantification 
GSH and GSSG contents in medial prefrontal cortex were measured using the 
colorimetric Tietze method. Briefly, tissue was sonicated in ice-cold PBS (150 mM NaCl, 3 mM 
KCl, 1.5 mM KH2PO4, 7.9 mM Na2HPO4, , 2.5 mM EDTA, pH=7.4). An aliquot was immediately 
reserved for protein quantification with the Advanced Protein Assay (Cytoskeleton, Denver, CO, 
USA).  In the remaining lysate, proteins were precipitated by adding 10% sulfosalicylic acid (for 
a final 0.5% solution). The lysate was then centrifuged for 10 min at 10000 rpm at 4°C and 
triethanolamine was added to the collected supernatant to adjust the pH to ~7.4. For the 
measurement of total GSH, an aliquot of supernatant was mixed with a freshly-made reaction 
solution containing at final concentration 0.5 U/ml GSH reductase from baker’s yeast (Sigma, 
St-Louis, MO, USA), 0.15 mM DTNB, 0.15 mM NADPH, and 1 mM EDTA. The rate of increase 
in absorbance at 405 nm, which measures the reduction of DTNB by GSH, is proportional to the 
total GSH. GSSG measurement was performed as for the total GSH. However, 2-vinylpyridine 
was first added to an aliquot of supernatant (final solution 1.8%) to derivatize GSH (1-h 
incubation) so only GSSG remained available for the reaction. For each sample, total GSH and 
GSSG were measured in duplicates. Concentrations of total GSH or GSSG in supernatants 
were determined by comparison with dilution series of GSH and GSSG solutions, respectively. 
Total GSH and GSSG contents in tissue were expressed in nmol/mg protein.  
2.8. Electrophysiology 
Mice were anesthetized with a mixture of ketamine/xylazine, and intracardiacally 
perfused with oxygenated sucrose-containing artificial cerebrospinal fluid (ACF) (in mM: 252 
sucrose, 3 KCl, 2 MgSO4, 1.2 CaCl2, 1.2 NaH2PO4, 24 NaHCO3, 10 glucose; pH 7.4) for ~10 
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min prior to decapitation. Paracoronal slices (400-µm thick, Bregma ~1.4-0.6) containing the 
ACC were prepared with a vibroslicer in cold oxygenated sucrose-containing ACF, transferred 
into a “Haas” type interface chamber and superfused with oxygenated normal ACF (in mM: 126 
NaCl, 3 KCl, 1 MgCl2, 1.2 CaCl2, 1.2 NaH2PO4, 24 NaHCO3, 10 glucose; pH 7.4). ACF 
temperature was slowly raised from room temperature to ~32°C. Electrophysiological recordings 
were performed at least 90 min after slicing. An ACF-filled glass electrode (~5 MΩ) was placed 
in the superficial part of layer V of the dorsal ACC (Cg1). Signals were band pass-filtered at 1-
1000 Hz and digitized at 2 kHz. Oscillatory neuronal activity was generated with a mixture of 
kainate (0.8 µM), carbachol, (50 µM), and quinpirole (1 µM) in 5 mM KCl-containing ACF 
(Steullet et al., 2014). Using the Welch method (IgorPro6 WaveMetrics, Portland, OR, USA), 
analysis of the power spectrum analyses was performed on a 60-sec recording taken after 25-
35 min incubation with the mixture of receptor agonists. The power spectrum was normalized so 
the power density between 100 and 1000 Hz was identical across recordings. The power 
density of fast oscillatory activity was calculated within the  band frequency (12-28 Hz). For 
each mouse, recordings were done bilaterally within 2 consecutive slices. Recordings that failed 
to display oscillatory activity with a peak frequency higher than 15 Hz were excluded from the 
final analysis.  
2.9. Statistics 
Statistics were performed with the SPPS software (IBM). Normality was tested by the 
Shapiro-Wilk test. When the variances were homogenous based on Levene’s test, data were 
analysed using univariate or multivariate analyses (general linear model), or Student t-test. Post 
hoc multiple comparisons were then performed using the Tukey HSD test. When the 
homogeneity of variances was not met, the Games-Howell test for multiple comparisons and the 
Welch’s t-test were used.  Quantification of mRNA expression was analyzed using a multivariate 
analysis (general linear model) with genotype and treatment as factors.  
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3. Results  
3.1. Delayed maturation of PVIs and PNNs in GRIN2A KO mice 
We first examined by immunohistochemistry parvalbumin-immunoreactive (PV-IR) 
neurons and PNNs in the ACC of GRIN2A KO and WT mice, at early postnatal age (PD20) and 
late adolescence / early adulthood (PD60). In WT mice, GluN2A is well expressed at PD20 
(Matta et al., 2013; Zhang and Sun, 2011) when PVIs / PNNs undergo maturation. While the 
number of PV-IR cells did not differ between genotypes at both ages (Fig. 1a, 2), the intensity of 
PV-IR in processes was significantly lower in young GRIN2A KO mice (Fig. 1b, 2). Similar effect 
was observed regarding PV-IR intensity (a.u.) in soma: PD20 KO mice displayed significantly 
weaker PV-IR labeling (43 ± 2,mean ± sem) as compared to PD60 KO (56 ± 1, p=0.001) and to 
PD60 WT mice (55 ± 3, p=0.005). Likewise, PNN intensity was weaker in PD20, but not PD60 
KO, as compared to age-matched WT mice (Fig. 1c, 2). The proportion of PV-IR cells wrapped 
with WFA-labeled PNNs was also lower in KO compared to WT mice at both ages (PD20: 57.2 
± 0.6 % in WT and 51.4 ± 1.1 % in KO (mean ± sem), p=0.004; PD60: 53.0 ± 1.1 % in WT and 
48.7 ± 0.4 % in KO, p=0.004, two-tailed Student t-test, Bonferroni corrected for multiple 
comparisons). These data indicate that absence of GluN2A delays maturation of PV-IR and 
PNNs. We also assessed oxidative stress in the ACC using an antibody against 8-oxo-dG. At 
both PD20 and PD60, we found no significant difference of 8-oxo-dG-IR between genotypes 
(Fig. 1d, 2), although 8-oxo-dG-IR intensity was slightly more elevated in KO mice at both ages, 
as compared with age-matched WT mice. .  
 
3.2. PVIs and PNNs are vulnerable to an early postnatal oxidative insult in GRIN2A KO mice  
The fact that the ACC of GRIN2A KO mice showed a delayed maturation of PNNs 
known to protect PVIs against oxidative stress (Cabungcal et al., 2013b), suggested that an 
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early-life oxidative insult might be detrimental to PVIs. This hypothesis was tested by applying 
an oxidative insult consisting of a daily treatment (from PD10 to 20) with the dopamine uptake 
inhibitor, GBR12909 (GBR). GBR elevates extracellular dopamine levels causing a subsequent 
generation of reactive oxygen species (ROS) and reactive compounds resulting from dopamine 
catabolism and auto-oxidation (Hastings et al., 1996; Hirrlinger et al., 2002). Immediately 
following the 10-days treatment, GBR-treated KO mice displayed significantly higher 8-oxo-dG-
IR in the ACC as compared to both WT groups (Fig. 3d, 4). The number of PV-IR cells and the 
intensity of PV-IR in processes were also significantly lower in GBR-treated KO mice, as 
compared to PBS- and GBR-treated WT mice (Fig. 3a,b, 4).  PV-IR intensity in soma was also 
significantly lower in GBR-treated KO (46 ± 2) as compared to PBS-treated WT mice (56 ± 2, 
p=0.023). Likewise, the intensity of WFA-labeled PNNs was weaker in GBR-treated KO mice 
than in both WT groups (Fig. 3c, 4). Thus, a postnatal oxidative insult in KO mice increases 
oxidative stress, which is accompanied with reduction in number of PV-IR cells, further 
weakening of PV-labeling and WFA-labeled PNNs. The antioxidant, N-acetylcysteine (NAC), 
provided from PD7 to PD20, was sufficient to prevent all GBR effects in KO mice (Fig. 3e-h, 4). 
Noteworthy, NAC restored PNNs to levels observed in naïve (Fig. 1c), or PBS-treated WT mice 
(Fig. 3c). Taken together, this shows that absence of GluN2A favors a susceptibility to oxidative 
stress-induced PVI / PNN defects.  
 
3.3. Weakened antioxidant defenses in GRIN2A KO mice 
As oxidative stress becomes prominent in the ACC of GRIN2A KO mice following a GBR 
treatment, we then explored the possible cause of such susceptibility to redox dysregulation. 
One hypothesis is that absence of GluN2A slightly compromises antioxidant systems. Synaptic 
NMDARs are indeed coupled with transcriptional control of several antioxidant systems (Baxter 
et al., 2015; Papadia et al., 2008). Therefore, we quantified the expression of genes implicated 
in the glutathione system (i.e., GCLC, GCLM, GPX1), thioredoxin system (i.e., TXNIP) and 
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peroxiredoxin (Prx) system (i.e., SRXN1) (Fig. 5), as well as in mitochondria and antioxidant 
support (i.e., PPARGC1a) in medial prefrontal cortex of PD20 WT and KO mice treated either 
with GBR or PBS. The expression of these genes are affected by pharmacologically-induced 
NMDAR hypofunction (Baxter et al., 2015; Jiang et al., 2013; Papadia et al., 2008). A 
multivariate analysis revealed a genotype (p=0.021), but no treatment effect and no interaction 
(Fig. 6a). In particular, there was a genotype effect on the expression of GCLM (p=0.003) and 
SRXN1 (p=0.007), which were both lower in KO compared to WT mice (Fig. 6a). GCLM codes 
for the modulatory subunit of the glutamate-cysteine ligase, the key synthesizing enzyme of 
glutathione (GSH), while SRXN1 codes for sulfiredoxin 1 whose function is to reduce 
hyperoxidized Prxs (Prx-SO2/3H). Moreover, the lowest expression of 4 out of the 6 investigated 
genes was found in GBR-treated KO mice (Fig. 6a). Thus, the absence of GluN2A decreases 
the transcription of some genes associated with the antioxidant defenses. Because of the 
reduced transcription of GCLM and SRXN1 in KO mice, we then examined whether levels of 
GSH, Prxs, and their respective redox state were altered in KO mice. Despite a reduced GCLM 
gene expression in KO mice, the total GSH content (sum of reduced and oxidized forms) was 
not different in both genotypes and not affected by the treatment (Fig. 6b). However, the level of 
oxidized GSH (GSSG) was significantly higher in GBR-treated KO mice as compared to PBS-
treated WT mice (Fig. 6c). Regarding the Prxs, we found that GBR treatment increased the 
amount of Prxs (~21 kDa band corresponding to Prx 1 and Prx 2) in WT but not in KO mice (Fig. 
6d,f). The ratio between hyperoxidized Prxs (Prx-SO2/3H) and total Prxs (2-Cys Prx) was not 
significantly different between groups, although hyperoxidation tended to be higher in GBR-
treated KO mice (Fig. 6e,f). Thus in KO mice, the impaired upregulation of Prxs in response to 
GBR may limit the capacity of the Prx system to neutralize ROS. This may account for the more 
oxidized redox states of GSH and Prxs, as well as higher 8-oxo-dG-IR in GBR-treated KO mice. 
These results indicate that a lack of GluN2A is accompanied with subtle alterations in gene or 
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protein expression of key elements of the GSH and Prx systems, which may contribute to the 
greater vulnerability of GRIN2A KO mice to oxidative insults as compared to WT mice. 
 
3.4. An early postnatal oxidative insult has long-term effects on PVI and PNN integrity in 
GRIN2A KO mice 
As early environmental stressors can cause long-term brain alterations in individuals with 
genetic susceptibility, we investigated the long-term effects of an early-life oxidative insult on the 
integrity of PVIs and PNNs in the ACC of PD60 GRIN2A KO mice. Previously, we have shown 
that a postnatal GBR treatment had no long-term effects on oxidative stress and PVI / PNN 
integrity in ACC of WT mice (Cabungcal et al., 2013a). Therefore, we only compared GBR-
treated KO mice with non-treated KO and WT mice. We observed that 8-oxo-dG-IR was 
significantly higher in GBR-treated KO than in non-treated KO and WT mice (Fig. 7d, 8). The 
number of PV-IR cells, the intensity of PV-IR in processes and WFA-labeling were lower in 
GBR-treated KO mice compared to the other groups (Fig. 7a-c, 8). PV-IR intensity in soma was 
also significantly lower in GBR-treated KO compared to PBS-treated KO mice (48 ± 2 vs. 56 ± 
1, p=0.011).  The proportion of PV-IR cells enveloped with WFA-labeled PNNs was also lower 
in GBR-treated KO (40.9 ± 2.4 %, mean ± sem) compared to non-treated WT (53.0 ± 1.1 %) 
and KO mice (48.7 ± 0.4 %) (p=0.002 and p=0.02, respectively, two-tailed Student t-test, 
Bonferroni corrected for multiple comparisons). These data demonstrate that an early-life 
oxidative insult causes persistent oxidative stress together with long-lasting impact on PVI and 
PNN integrity in the ACC of GRIN2A KO mice. 
 
3.5. An early postnatal oxidative insult causes long-term microglia activation in GRIN2A KO 
mice 
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Since an early-life GBR treatment caused a long-term increase in oxidative stress in the 
ACC of KO mice, we explored whether this was accompanied with a persisting activation of 
microglia. Assessment of microglia was performed by immunohistochemistry using an antibody 
against Iba1, a microglia/macrophage-specific marker, and an antibody against CD68, a 
glycoprotein highly expressed in activated microglia. We found a significant difference in the 
number of CD68-IR cells, but not Iba1-IR cells, between PD60 non-treated WT and KO mice 
(Fig. 7e,f, 9). But most notably, the numbers of Iba1-IR and CD68-IR cells were higher in GBR-
treated KO mice as compared to non-treated WT and KO mice. Such effect of GBR on microglia 
was not observed in WT mice (Dwir et al. Society of Neuroscience abstract 2016). Moreover, 
Iba1-IR cells in GBR-treated KO mice displayed amoeboid shapes. These indicate that GRIN2A 
KO mice show a vulnerability for microglia activation and that an early-life oxidative insult 
promotes long-term phagocytic-like state of microglia in these mice. 
 
3.6. An early postnatal oxidative insult has a modest long-term effect on local fast oscillatory 
neuronal activity in GRIN2A KO mice 
We examined whether local fast oscillatory neuronal activity in the ACC of PD60 GRIN2A 
KO mice was also affected by an early-life GBR treatment. High-frequency oscillations (in β 
range: 12-28Hz) were induced pharmacologically in ACC slices with the superfusion of 
carbachol, kainate and quinpirole. This fast oscillatory activity requires GABAA and AMPA 
receptors, as well as gap junctions (Steullet et al., 2014), and is impaired when there is a 
reduced number of PV-IR cells in a mouse model of redox dysregulation (Cabungcal et al., 
2013b). First, we checked whether GBR had an effect on high-frequency oscillations in WT 
mice. We found no difference in oscillation power and peak frequency between PBS- and GBR-
treated WT mice (Fig. 10a,c,e). By contrast, GBR significantly decreased the oscillation power 
in KO mice (p=0.009, one-tailed t-test; Fig. 10b,d), but had no effect on the peak frequency (Fig. 
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10f). Together, this indicates that an early-life oxidative insult impacts modestly local high-
frequency oscillations in the ACC of late adolescent / young adult GRIN2A KO mice.  
 
4. Discussion  
This study reveals that a lack of GluN2A leads to sub-threshold oxidative stress and delays 
maturation of PNNs and PVIs in the ACC. These effects appear to be caused by a dysregulated 
modulation of antioxidant systems. Consequently, an early-life oxidative insult results in 
persistent oxidative stress, microglia activation, decrease in PV-IR and WFA-labeled PNN 
integrity.  
Our finding that GluN2A favors PNN and PVI maturation is consistent with the notion 
that NMDAR subunit plays an important role in cortical network refinement during postnatal 
development. GluN2A deletion impairs the development of orientation preference through 
sensory experience and weakens cortical plasticity to monocular deprivation in visual cortex 
(Fagiolini et al., 2003). This plasticity can be restored by diazepam indicating an excitation / 
inhibition imbalance in young GRIN2A KO mice. While studies using a GluN2A-containing 
NMDAR antagonist suggest that GluN2A is implicated in both PVI maturation and phenotypic 
maintenance (Kinney et al., 2006; Zhang and Sun, 2011), we demonstrate in this study that this 
receptor subtype plays an essential role in PVI maturation, but not phenotypic maintenance.  
Thus, a lack of GluN2A delays maturation of PNNs and PV-IR without impacting PV-IR and 
PNNs at late adolescence / early adulthood. PNN expression depends on neuronal activity 
(McRae et al., 2007) and requires calcium signaling (Dityatev et al., 2007). Here, we show that 
the antioxidant NAC prevents the delayed PNN formation in GRIN2A KO mice. This strongly 
suggests that the slowing down of PNN maturation in absence of GluN2A is mostly driven by a 
redox dysregulation as evidenced by a sub-threshold level of oxidative stress, which is known to 
delay WFA-labeled PNN formation (Cabungcal et al., 2013b). However, we cannot fully exclude 
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that the boosting effect of NAC on PNN maturation in KO mice occurs via an upregulation of the 
glial glutamate transporter GLT-1 and the cystine-glutamate exchanger xCT (McClure et al., 
2014), leading to changes in extracellular glutamate levels and in activation of synaptic and 
extrasynaptic glutamate receptors also involved in PNN maturation. Our results suggest that the 
redox dysregulation in GRIN2A KO mice is caused by altered modulation of several antioxidant 
systems, including the GSH and Prx systems. Activation of synaptic NMDARs indeed regulates 
the transcription of genes associated with the GSH, Prx, and thioredoxin systems to support 
antioxidant defense and redox control in an activity-dependent manner (Baxter et al., 2015; 
Papadia et al., 2008). The expression of genes associated with several antioxidant systems and 
mitochondrial function is impaired upon conditional deletion of the NR1 subunit in forebrain 
interneurons (Jiang et al., 2013). NMDARs can modulate antioxidant systems via multiple 
transcription factors (e.g. CREB, FOXO, ATF4) (Papadia et al., 2008). It is therefore possible 
that not one, but several pathways are slightly dysregulated by a lack of GluN2A. Indeed, further 
investigations will be required to identify the pathway(s) responsible for the subtle dysregulation 
of the antioxidant defense in GRIN2A KO mice. Additionally, a lack of GluN2A might reinforce 
the impact of GluN2B-mediated signaling cascades in neurons, one of them leading to NADPH 
oxidase-mediated superoxide production (Costa et al., 2012). For example, a specific GluN2A 
antagonist increased superoxide production in prefrontal cortex of young mice (Powell et al., 
2012). Our data suggest that GluN2A-containing NMDARs sense network activity to maintain 
adequate redox control, which is particularly critical during postnatal development.  Collectively, 
the present study proposes a novel mechanism by which GluN2A-containing NMDARs not only 
determines the direction of synaptic plasticity (Cho et al., 2009) but also mildly regulates redox-
sensitive molecular mechanisms involved in cortical development and refinement. This includes 
regulation of the building up and maturation of PNNs. Environmental enrichment (EE) is also 
known to delay PNN development and modulate PNN integrity and composition. Depending on 
brain regions, EE weakens or enhances PNNs (Foscarin et al., 2011; Slaker et al., 2016). 
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However, the dynamic regulation of synthesis and removal of extracellular matrix components 
by EE likely involve mechanisms independent of oxidative stress. 
The perturbed redox regulation and PNN deficit in ACC of PD20 GRIN2A KO mice also 
confer an increased susceptibility to an early-life oxidative insult. Previously, we have shown 
that a treatment with GBR leads to an excess of oxidative stress in ACC of young mice with a 
GSH deficit, but not in WT mice (Cabungcal et al., 2013a). Likewise, a GBR treatment increases 
oxidative stress and decreases PV-IR and PNN integrity in ACC of PD20 GRIN2A KO. The 
GBR effects are prevented by NAC, proving the pivotal role of redox dysregulation. This is 
consistent with the notion that redox dysregulation / oxidative stress constitutes a convergent 
pathological pathway causing PNN / PVI anomalies in many animal models relevant to SZ 
(Steullet et al., 2017). In GRIN2A KO mice, the impaired upregulation of Prxs in response to 
GBR may compromise the ability to adequately neutralize an excess of ROS production, leading 
to oxidative stress, PV-IR decrease and PNN deficit. Remarkably, the increased oxidative stress 
induced by an early-life GBR treatment persists until late adolescence / young adulthood 
together with the reduction of PV-IR, weakening of WFA-labeled PNNs, and activation of 
microglia in a phagocytic-like state. The reason for the persistence of oxidative stress and 
microglia activation following an early-life oxidative insult in GRIN2A KO mice might be directly 
linked to their sub-optimal antioxidant and redox regulation capacities. While an impaired redox 
regulation favors oxidative stress and microglia activation during an oxidative insult (i.e., GBR 
treatment), it may likewise prevent these glial cells to return into their inactivated state. Indeed, 
the phenotype of microglia is tightly regulated by the thiol redox status (Rojo et al., 2014), 
whereby an appropriate reduced redox state is necessary for microglia inactivation. In a feed-
forward process, the failure of microglia to switch back into a “resting” phenotype after being 
activated by an early insult could in turn maintain long-lasting oxidative stress leading to 
persistent PVI and PNN deficits.  
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In psychiatric diseases such as SZ, abnormal glutamatergic transmission, oxidative stress 
and microglia activation are commonly reported. The present study demonstrates that NMDAR 
hypofunction can be an upstream event of oxidative stress and neuroinflammation.  This does 
not rule out, however, other possible scenarios whereby redox dysregulation or 
neuroinflammation could be primary cause for the disruption of the homeostasis between these 
tightly and reciprocally interconnected systems. In this context, the GluN2A subunit may play a 
pivotal role. Altered GluN2A expression is reported following social isolation, which also induces 
oxidative stress and microglia activation (Schiavone et al., 2012; Turnock-Jones et al., 2009): 
this might represent adaptive and/or compensatory mechanisms to stressors. Interestingly, 
GluN2A-containing NMDARs are themselves redox-sensitive and their function diminishes 
under oxidative conditions (Choi et al., 2001; Kohr et al., 1994). A priori, this appears 
counterintuitive as GluN2A contributes to the regulation of antioxidant capacity and redox 
balance. One hypothesis is that a strong GluN2A-mediated signaling could be deleterious in 
some conditions. For instance, an overexpression of GluN2A in prefrontal cortex during 
adolescence is responsible for the anxious behavior and the decreased number of PV-IR cells 
caused by a maternal separation in rats (Ganguly et al., 2015).  
 
5. Conclusions  
To conclude, a lack of GluN2A-dependent signaling confers a vulnerability to early-life 
stressors that affect PVIs and extracellular matrix via an inappropriate regulation of redox and 
immune systems. This could be relevant to SZ and but also other neurodevelopmental disorders 
associated with GRIN2A mutations such as epilepsy-aphasia. In the latter syndrome, same 
GRIN2A gene mutation can cause mild to severe symptoms, suggesting that other genetic and 
environment factors may play a role in the severity of the pathology (Burnashev and 
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Szepetowski, 2015; Hardingham and Do, 2016). Thus, antioxidant could be potentially beneficial 
to patients with a defect in GluN2A-containing NMDARs.    
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Figure legends 
Fig. 1. Delayed maturation of parvalbumin interneuron processes and perineuronal nets 
(PNNs), and sub-threshold oxidative stress in the anterior cingulate cortex (ACC) of 
GRIN2A KO mice. A Number of parvalbumin-immunoreactive (PV-IR) cells in ROI delineating 
the ACC. B Intensity (a.u.) of PV-IR within processes. C Intensity (a.u.) of labeling of WFA-
PNNs. D Intensity (a.u.) of 8-oxo-dG-IR. Box plots depict medians and quartiles; bars show 
values in the 1.5 box length range. WT at PD20 (2 males, 2 females); WT at PD60 (2, 3); KO at 
PD20 (3, 3); KO at PD60 (6, 2). * p<0.05, ** p<0.01, *** p<=0.001 (multiple comparisons using 
either Tukey HSD test or Games-Howell test).  
 
Fig. 2. A Representative images of parvalbumin, WFA, and 8-oxo-dG labeling in the ACC 
of PD20 WT and GRIN2A KO mice. Scale: 50 µm. B Higher magnification images showing PV-
IR processing in superficial and deep layers of both WT and KO mice. Scale: 20 µm. C Higher 
magnification image illustrating the WFA staining associated with PV-IR cells. Scale: 20 µm. 
Note that in both B and C, the PV labeling was enhanced for display purpose only in order to 
better show PV-IR processes. Therefore, PV labeling in soma appears saturated in these 
images. D Schema showing the region of interest (ROI) in the ACC (cg1) in which quantification 
of PV-IR, 8-oxo-dG-IR and WFA staining was performed. CC: corpus callosum. 
 
Fig. 3. Early-life treatment with the dopamine uptake inhibitor, GBR12909 (GBR), 
increases oxidative stress, and affects parvalbumin interneurons and perineuronal nets 
(PNNs) in the ACC of PD20 GRIN2A KO mice. A Number of parvalbumin-immunoreactive 
(PV-IR) cells. B Intensity (a.u.) of PV-IR within processes. C Intensity (a.u.) of labeling of WFA-
PNNs. D Intensity (a.u.) of 8-oxo-dG-IR. WT PBS (5 males, 2 females); WT GBR (4, 3); KO 
PBS (3, 3); KO GBR (3, 4). E-H Treatment of KO mice with N-acetylcysteine (NAC) prevents 
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GBR-induced oxidative stress (H), reduction in number of PV-IR cells (E) and PV-IR intensity in 
processes (F), and re-establishes normal levels of WFA-labeled PNNs (G). For A-D: * p<=0.05, 
** p<=0.01, *** p<=0.001 (multiple comparisons using the Tukey HSD test). For E-H: ***: 
p<0.0005 (two-tailed Student or Welch’s t-test). KO GBR (3 males, 2 females), KO GBR+NAC 
(4, 4). Box plots depict medians and quartiles; bars show values in the 1.5 box length range.  
 
Fig. 4.  Effect of early-life treatment with the dopamine uptake inhibitor, GBR12909 (GBR) 
on oxidative stress, parvalbumin interneurons, and perineuronal nets (PNNs) in the ACC 
of PD20 GRIN2A KO mice. Representative images of parvalbumin immunoreactivity, WFA-
labeled PNNs, and 8-oxo-dG labeling in the ACC of PBS- treated and GBR-treated WT mice, 
PBS-treated and GBR-treated KO mice, and GBR-treated KO mice treated with N-
acetylcysteine (NAC). Scale: 50 µm. 
 
Fig. 5. Simplified scheme of the glutathione (GSH), thioredoxin (Trx), and peroxiredoxin 
(Prx) systems. Enzyme names are given in italic. GPx, glutathione peroxidase; GR, glutathione 
reductase; TrxR, thioredoxin reductase; Cys, cysteine; Glu, glutamate; Glu-Cys, 
glutamylcysteine; GSSG, oxidized GSH; Txnip, thioredoxin-interacting protein. Txnip interacts 
with reduced Trx to block the reduction by Trx of its substracts (e.g. oxidized 2-Cys Prxs). Here, 
Prx represent only the 2-cys Prxs. For simplification, only one of the sulfur group from the two 
cys residues in the Prx is presented in its different redox states (reduced: -SH, sulfenic: -SOH, 
sulfinic: -SO2H, disulfide: S-S). R can be a Prx or other molecules interacting with oxidized Prx 
to form disulfide bridges. 
  
Fig. 6. Regulation of antioxidant systems is altered in GRIN2A mice. A Expression of genes 
associated with antioxidant systems and mitochondrial support in the medial prefrontal cortex of 
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PBS- and GBR-treated WT and KO mice (at PD20). Values are expressed relative to the 
average expression in WT PBS mice after normalization using TBB5 and RPL27 as internal 
controls. Multivariate analysis shows a genotype effect on GCLM (F[1,35]=9.918; p=0.003) and 
SRXN1 (F[1,35]=8.366; p=0.007) expression. WT PBS (5 males, 5 females); WT GBR (6, 4); 
KO PBS (5, 5); KO GBR (4, 5). * indicates significant difference with WT. B-E Content of GSH 
and 2-Cys peroxiredoxins (Prxs), and their redox state in the medial prefrontal cortex of PBS- 
and GBR-treated WT and KO mice (at PD20). B Content in total GSH and C oxidized GSH 
(GSSG). WT PBS (3 males, 3 females); WT GBR (3, 3); KO PBS (3, 3); KO GBR (3, 3). D 
Content in 2-Cys Prxs (21 kDa band, see F). Values (arbitrary unit) are normalized with β-actin 
as internal control. E Ratio between hyperoxidized 2-Cys Prxs (Prx-SO2/3H) and total 2-Cys Prxs 
at the 21 kDa band. WT PBS (3 males, 2 females); WT GBR (3, 2); KO PBS (3, 2); KO GBR (3, 
2). For B-E: * p<=0.05, (*) p=0.067 (multiple comparisons using Tukey HSD test). Box plots 
depict medians and quartiles; bars show values in the 1.5 box length range. F Representative 
Western blot showing the band for β-actin and the bands at 21 and 24 kDa which are 
recognized by the antibodies against 2-Cys Prxs and against Prx-SO2/3H. Note that the Prxs at 
24 kDa was not different across groups and the Prx-SO2/3H band at 24 kDa was hardly visible 
and therefore not analyzed.  
 
Fig. 7. Long-term effects of early-life GBR treatment on oxidative stress, parvalbumin 
interneurons, perineuronal nets (PNNs), and microglia activation in the ACC of PD60 
GRIN2A KO mice. A Number of parvalbumin-immunoreactive (PV-IR) cells. B Intensity (a.u.) of 
PV-IR within processes. C Intensity (a.u.) of labeling of WFA-PNNs. D Intensity (a.u.) of 8-oxo-
dG-IR. E Number of Iba1-IR cells. F Number of CD68-IR cells. Different from KO: * p<0.05, ** 
p<0.01, *** p<0.001; different from WT: #  p<0.05, # # p<0.01, # # # p<0.001 (multiple 
comparisons using Tukey HSD test or Games-Howell test) . For A-D: WT (2 males, 3 females); 
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KO (6, 2); KO GBR (4, 4). For E-F: WT (3 males, 2 females); KO (3, 2); KO GBR (3, 2). Box 
plots depict medians and quantiles; bars show values in the 1.5 box length range.  
 
Fig. 8.  Long-term effects of early-life GBR treatment on oxidative stress, parvalbumin 
interneurons, and perineuronal nets (PNNs) in the ACC of PD60 GRIN2A KO mice. 
Representative images of parvalbumin immunreactivity, WFA-labeled PNNs, and 8-oxo-dG 
labeling in the ACC of non-treated WT and KO mice, and GBR-treated KO mice. Scale: 50 µm. 
 
Fig. 9.  Long-term effects of early-life GBR treatment on microglia activation in the ACC 
of PD60 GRIN2A KO mice. Representative images of Iba1 and CD68 immunoreactivity in the 
ACC of non-treated WT and KO mice, and GBR-treated KO mice. Scale: 20 µm. 
 
Fig. 10. Long-term effect of early-life GBR treatment on local high-frequency oscillatory 
activity induced in ACC slices of PD60 GRIN2A KO mice. Power spectrum (median) of 
neuronal activity induced in ACC slices by a mixture of carbachol, kainate, and quinpirole in (A) 
PBS- and GBR-treated WT mice and in (B) PBS- and GBR-treated KO mice. Power of β 
frequency (12-28 Hz) oscillations in (C) WT and (D) KO mice. Peak frequency of oscillations in 
(E) WT and (F) KO mice. Number of slices: 28 WT PBS, 25 WT GBR, 21 KO PBS, 34 KO GBR. 
Slices are from similar numbers of males and females. * p<0.05 (two-tailed Student t-test). Box 
plots depict medians and quartiles; bars show values in the 1.5 box length range. 
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